Doctors Without Borders/Médecins Sans Frontières (MSF) supports the Belarusian Ministry of Health to treat patients with multidrug-resistant tuberculosis (MDR-TB).
Belarus is listed as a high-burden country for MDR-TB in the World Health Organization’s 2019 Global Tuberculosis Report. Learn how you can best help in Belarus and other countries.
In 2019, we supported the Ministry of Health in four TB facilities in Minsk, the capital, and in Volkovichi village in Minsk region. Our teams also regularly visited a penal colony in Orsha to assist with the treatment of inmates with drug-resistant TB (DR-TB) and co-infections. By the end of 2019, 54 patients with hepatitis C had received treatment with direct-acting antiviral drugs. Please donate to support our work in Belarus and other countries around the world now.
MSF, together with the Ministry of Health, devised a harm-reduction program with the goal of helping patients with DR-TB and alcohol-use problems to manage their dependency on alcohol and other substances in order to finish their treatment successfully. Our psychosocial support team conducted a total of 4,255 consultations in 2019, with around 70-80 patients receiving consultations each month. We also initiated a study to demonstrate the effectiveness and feasibility of this program.
Minsk is one of the five sites of the MSF-sponsored TB PRACTECAL clinical trial, which is looking into short, innovative MDR-TB treatment regimens. By the end of 2019, 51 patients had been recruited for the trial.
Minsk is also one of the 17 sites of the end TB observational study, which is evaluating the safety and efficacy of the newer TB drugs bedaquiline and delamanid. In 2019, the team continued to follow up the 122 patients enrolled in the study.